Showing results (81-90 of 317) with videos related to
Sort By:
Pageof 32
Tumori|October 13, 2011
Use of metronomic chemotherapy in oncology: results from a national Italian surveyElena Collovà, Federica Sebastiani, Elisabetta De Matteis, et al.Immunotherapy|May 8, 2019
Avelumab in gastric cancerGiandomenico Roviello, Alberto D'Angelo, Daniele Generali, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
Intermediate endpoints of primary systemic therapy in breast cancer patientsAlfredo Berruti, Daniele Generali, Valentina Bertaglia, et al.Journal of the National Cancer Institute. Monographs|June 12, 2015
RNA Disruption and Drug Response in Breast Cancer Primary Systemic TherapyKenneth Pritzker, Laura Pritzker, Daniele Generali, et al.Acta Chirurgica Belgica|August 4, 2018
Familial aggregation of gastric cancer with microsatellite instabilityKarol Polom, Daniele Marrelli, Costantino Voglino, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 18, 2016
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancerKarol Polom, Giandomenico Roviello, Daniele Generali, et al.Critical Reviews in Oncology/Hematology|December 10, 2016
New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trialsGiandomenico Roviello, Laura Zanotti, Maria Rosa Cappelletti, et al.Breast Cancer Research and Treatment|June 6, 2015
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancerDaniele Generali, Sergio Venturini, Carla Rognoni, et al.Expert Review of Clinical Pharmacology|August 23, 2016
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patientsFrancesca Poggio, Matteo Lambertini, Eva Blondeaux, et al.Cells|July 18, 2018
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast CancerNavid Sobhani, Anna Ianza, Alberto D'Angelo, et al.Pageof 32